Treatment of isoniazid-resistant pulmonary tuberculosis

Treatment of isoniazid-resistant pulmonary tuberculosis

<p>Abstract</p> <p>Background</p> <p>Although resistance to isoniazid (INH) is the most common form of drug resistance seen among <it>Mycobacterium tuberculosis </it>isolates, there have been few studies on the efficacy and optimal duration of treatment for...

Full description

Bibliographic Details
Main Authors:	Lim Si, Lim Seong, Kwon O Jung, Kim Hojoong, Chung Man, Suh Gee, Kim Yee, Koh Won-Jung
Format:	Article
Language:	English
Published:	BMC 2008-01-01
Series:	BMC Infectious Diseases
Online Access:	http://www.biomedcentral.com/1471-2334/8/6

Similar Items

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
by: Byung Woo Jhun, M.D., et al.
Published: (2020-01-01)

Re-evaluating the role of isoniazid in treatment of pulmonary tuberculosis
by: Scott Heysell, et al.
Published: (2020-06-01)

Isoniazid and Pulmonary Fibrosis
by: Chae Uk Chung, et al.
Published: (2015-01-01)

Isoniazid resistance in Mycobacterium tuberculosis
by: Tho, Dau Quang
Published: (2012)

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.
by: Raymund Dantes, et al.
Published: (2012-01-01)

Risk factors for treatment failure in isoniazid resistant tuberculosis
by: Phan, Vuong Khac Thai
Published: (2014)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
by: Chih-Cheng Lai, et al.
Published: (2011-09-01)

Timing of silicone stent removal in patients with post-tuberculosis bronchial stenosis
by: Jung Seop Eom, et al.
Published: (2013-01-01)

RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS
by: I. A. Burmistrova, et al.
Published: (2019-01-01)

Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis
by: Wiens, Theresa M.
Published: (2009)

Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis
by: Wiens, Theresa M.
Published: (2009)

Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)

Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
by: Renata Báez-Saldaña, et al.
Published: (2016-01-01)

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru.
by: Leonela Villegas, et al.
Published: (2016-01-01)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
by: Maria Elvira Balcells, et al.
Published: (2006-05-01)

Risk factors associated with isoniazid resistance in tuberculosis
by: Barnard, Marinus
Published: (2008)

Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis
by: Hyun Jin Cho, et al.
Published: (2020-01-01)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
by: Jung JA, et al.
Published: (2015-09-01)

Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
by: Valéria G. F. Pinheiro, et al.

High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
by: Naima Fasih, et al.
Published: (2012-01-01)

Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China
by: Guilian Li, et al.
Published: (2020-03-01)

Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis
by: Hyun Lee, et al.
Published: (2017-12-01)

A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018
by: Yan Shao, et al.
Published: (2020-09-01)

Molecular characterization of Mycobacterium tuberculosis strains resistant to isoniazid
by: Salma Smaoui, et al.
Published: (2016-01-01)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
by: Elsje Pienaar, et al.
Published: (2018-01-01)

Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
by: Phan Vuong Khac Thai, et al.
Published: (2018-03-01)

The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study.
by: Kamila Romanowski, et al.
Published: (2019-01-01)

Treatment Success in Patients with Drug-Resistant Pulmonary Tuberculosis in Cavitation of S6 of Lungs and Concomitant Endobronchial Pathology Using Isoniazid-Hydroxymethylquinoxalinedioxyde in the Comprehensive Treatment
by: O.M. Raznatovska, et al.
Published: (2015-11-01)

Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis
by: Brian Cody Adkinson, et al.
Published: (2020-11-01)

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment
by: Konstantina Chachlioutaki, et al.
Published: (2020-05-01)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
by: Kamila Romanowski, et al.
Published: (2017-09-01)

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
by: Zayniddin Sayfutdinov, et al.
Published: (2021-03-01)

Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
by: Diana Machado, et al.
Published: (2012-01-01)

Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009.
by: Helen E Jenkins, et al.
Published: (2011-01-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis.
by: Sebastian Gagneux, et al.
Published: (2006-06-01)

Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis
by: Saba Kabir, et al.
Published: (2021-02-01)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
by: A. V. Zаkhаrov, et al.
Published: (2017-06-01)

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
by: Jose Gabriel Cornejo Garcia, et al.
Published: (2018-01-01)